(Q46109460)

English

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Olav Dahl

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

2

object named as

Øystein Fluge

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

6

object named as

Barthold Vonen

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Norwegian Gastrointestinal Cancer Group

12

object named as

Norwegian Gastrointestinal Cancer Group

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

author name string

Erik Carlsen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Johan N Wiig

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Helge E Myrvold

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Nina Podhorny

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Ottar Bjerkeset

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Tor Jack Eide

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Tore B Halvorsen

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Kjell Magne Tveit

11

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

48

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

368-376

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant therapy of colorectal cancer. Why we still don't know

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant therapy for stage II colon cancer: an elephant in the living room?

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

An overview of adjuvant therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant management of rectal cancer: the more we learn, the less we know

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Current options for the management of rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

The microsatellite instability phenotype in human colorectal carcinoma: relationship to sex, age, and tumor site

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Sex differences in colorectal cancer mortality in Europe, 1955–1996

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Colorectal cancer survival trends in Norway 1958–1997

1 reference

https://api.crossref.org/works/10.1080%2F02841860902755244

21 January 2018

Identifiers

10.1080/02841860902755244

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19242829

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46109460&oldid=2119344919"